AAAAAA
Results:
1-15
|
Results: 15
Authors:
Cass, I
Baldwin, RL
Fasylova, E
Fields, AL
Klinger, HP
Runowicz, CD
Karlan, BY
Citation: I. Cass et al., Allelotype of papillary serous peritoneal carcinomas, GYNECOL ONC, 82(1), 2001, pp. 69-76
Authors:
Cass, I
Li, AJ
Runowicz, CD
Fields, AL
Goldberg, GL
Leuchter, RS
Lagasse, LD
Karlan, BY
Citation: I. Cass et al., Pattern of lymph node metastases in clinically unilateral stage invasive epithelial ovarian carcinomas, GYNECOL ONC, 80(1), 2001, pp. 56-61
Authors:
Chen, LM
Karlan, BY
Citation: Lm. Chen et By. Karlan, Recurrent ovarian carcinoma: Is there a place for surgery?, SEM SURG ON, 19(1), 2000, pp. 62-68
Authors:
Crump, C
McIntosh, MW
Urban, N
Anderson, G
Karlan, BY
Citation: C. Crump et al., Ovarian cancer tumor marker behavior in asymptomatic healthy women: Implications for screening, CANC EPID B, 9(10), 2000, pp. 1107-1111
Authors:
Brown, JV
Peters, WA
Rettenmaier, MA
Karlan, BY
Dillman, RA
Smith, MR
Drescher, CW
Micha, JP
Citation: Jv. Brown et al., A phase I trial of a 3-day topotecan Q 21 days for recurrent epithelial cancers of the ovary, fallopian tube, and peritoneum, GYNECOL ONC, 79(3), 2000, pp. 495-498
Authors:
Chen, LM
Leuchter, RS
Lagasse, LD
Karlan, BY
Citation: Lm. Chen et al., Splenectomy and surgical cytoreduction for ovarian cancer, GYNECOL ONC, 77(3), 2000, pp. 362-368
Authors:
Ismail, RS
Baldwin, RL
Fang, JG
Browning, D
Karlan, BY
Gasson, JC
Chang, DD
Citation: Rs. Ismail et al., Differential gene expression between normal and tumor-derived ovarian epithelial cells, CANCER RES, 60(23), 2000, pp. 6744-6749
Authors:
Baldwin, RL
Nemeth, E
Tran, H
Shvartsman, H
Cass, I
Narod, S
Karlan, BY
Citation: Rl. Baldwin et al., BRCA1 promoter region hypermethylation in ovarian carcinoma: A population-based study, CANCER RES, 60(19), 2000, pp. 5329-5333
Authors:
Schummer, M
Ng, VLV
Baumgarner, RE
Nelson, PS
Schummer, B
Bednarski, DW
Hassell, L
Baldwin, RL
Karlan, BY
Hood, L
Citation: M. Schummer et al., Comparative hybridization of an array of 21 500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas, GENE, 238(2), 1999, pp. 375-385
Authors:
Yamada, SD
Baldwin, RL
Karlan, BY
Citation: Sd. Yamada et al., Ovarian carcinoma cell cultures are resistant to TGF-beta 1-mediated growth inhibition despite expression of functional receptors, GYNECOL ONC, 75(1), 1999, pp. 72-77
Authors:
Baldwin, RL
Tran, H
Karlan, BY
Citation: Rl. Baldwin et al., Primary ovarian cancer cultures are resistant to Fas-mediated apoptosis, GYNECOL ONC, 74(2), 1999, pp. 265-271
Authors:
Bristow, RE
Montz, FJ
Lagasse, LD
Leuchter, RS
Karlan, BY
Citation: Re. Bristow et al., Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer, GYNECOL ONC, 72(3), 1999, pp. 278-287
Authors:
Bristow, RE
Baldwin, RL
Yamada, SD
Korc, M
Karlan, BY
Citation: Re. Bristow et al., Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma, CANCER, 85(3), 1999, pp. 658-668
Authors:
Karlan, BY
Baldwin, RL
Lopez-Luevanos, E
Raffel, LJ
Barbuto, D
Narod, S
Platt, LD
Citation: By. Karlan et al., Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: Implications for ovarian cancer screening, AM J OBST G, 180(4), 1999, pp. 917-925
Authors:
Karlan, BY
Citation: By. Karlan, Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: Implications for ovarian cancer screening - Discussion, AM J OBST G, 180(4), 1999, pp. 927-928
Risultati:
1-15
|